Craft

Walvax Biotechnology

Stock Price

¥10.1

2024-09-12

Market Capitalization

¥16.1 B

2024-09-12

Revenue

¥4.1 B

FY, 2023

Walvax Biotechnology Summary

Company Summary

Overview
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. It offers valent pneumococcal, meningococcal, diphtheria and tetanus, human papillomavirus bivalent vaccines, and other products.
Type
Public
Status
Active
Founded
2001
HQ
Kunming, CN | view all locations
Website
https://en.walvax.com/
Cybersecurity rating
Sectors

Key People

  • Yunchun Li

    Yunchun Li, Chairman

    • Zhen Huang

      Zhen Huang, Vice Chairman

      • Shaozhong Dong

        Shaozhong Dong, Vice Chairman

        • Wei Yao

          Wei Yao, President

          LocationsView all

          1 location detected

          • Kunming, Yun Nan Sheng HQ

            China

            No. 395 Kexin Road, Wuhua District

          Walvax Biotechnology Financials

          Summary Financials

          Revenue (Q1, 2024)
          ¥595.6M
          Gross profit (Q1, 2024)
          ¥482.1M
          Net income (Q1, 2024)
          ¥38.3M
          Cash (Q1, 2024)
          ¥4.1B
          EBIT (Q1, 2024)
          ¥42.4M
          Enterprise value
          $12.8B

          Footer menu